Investigation Overview
September 20, 2016 (Shareholders Foundation) - An investigation on behalf of investors, who currently hold shares of Raptor Pharmaceutical Corp. (NASDAQ:RPTP), was announced concerning whether the takeover of Raptor Pharmaceutical Corp. by Horizon Pharma plc for $9.00 per share is unfair to NASDAQ:RPTP stockholders. The investigation by a law firm concerns whether certain officers an...
You must register (for free) or login to view the entire investigation.